REGENTIS BIOMATERIALS LTD.

Notice of Effectiveness

Post-effective amendment to a registration statement

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Registration statement for securities of certain foreign private issuers

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

<ITEMS>06c

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Withdrawal of a registration statement

Registration statement for securities of certain foreign private issuers (amendment)

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (amendment)

Free Writing Prospectus

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Registration statement for securities of certain foreign private issuers

Registration statement / Annual report / Transition report for Foreign Private Issuers (amendment)

Registration statement / Annual report / Transition report for Foreign Private Issuers

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Draft registration statement (confidential submission)

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Prospectus Supplement for Primary Offering

Certification of approval for listing and registration on a national securities exchange

Registration statement for securities of certain foreign private issuers (amendment)

Free Writing Prospectus

Free Writing Prospectus

Registration statement for securities of certain foreign private issuers (amendment)

Registration of Securities on Exchange

Registration statement for securities of certain foreign private issuers (amendment)

Free Writing Prospectus

Draft registration statement (confidential submission) (amendment)

Draft registration statement (confidential submission) (amendment)

Draft registration statement (confidential submission)

Draft registration statement (confidential submission)

Draft registration statement (confidential submission) (amendment)

Draft registration statement (confidential submission) (amendment)

Draft registration statement (confidential submission) (amendment)

Draft registration statement (confidential submission)

Dykan Jeff

Valentine Keith

Ben-Elazar Pini

Alpert Susan PHD MD

GELLER EHUD

Cohen-Arazi Efraim

Reske Galit

Gordashnikov Arie

GELLER EHUD

Alpert Susan PHD MD

Ben-Elazar Pini

Gon Ori

Cohen-Arazi Efraim

Dykan Jeff

Valentine Keith